Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

TMS Early Intervention After Trauma to Boost Resilience

Official title: PREVENT Study: Promoting Resilience Via Early Neurostimulation After Trauma

Run by Emory University · NCT07568145 · Data updated 2026-11-12

A short brain-stimulation treatment (TMS) is tried shortly after a traumatic event to see if it helps prevent long-term PTSD and depression in people 18–65.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorEmory University
Academic / other
Locations2 sites (Atlanta, Georgia and 1 other locations)
StatusRecruiting
StartedJune 18, 2026
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedSeptember 8, 2026
Trial IDNCT07568145 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–65 who recently experienced trauma (within 2 weeks) and have high acute PTSD symptoms but low lifetime PTSD burden.

Probably not a fit

Individuals with ongoing high suicide risk or unstable medication changes may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests Transcranial Magnetic Stimulation (TMS) as an early intervention after a traumatic event. Participants are adults who recently experienced trauma and have higher PTSD symptoms but no prior full PTSD from earlier traumas. They are randomly assigned to active TMS or a sham procedure to see if brain stimulation changes neural reactivity related to threat and reduces the chance of chronic PTSD. The approach focuses on the weeks following trauma, a critical window where early treatment may improve outcomes. The study is conducted at Grady Memorial Hospital and Emory Brain Health Center in Atlanta, with Emory University as the lead sponsor and NIMH collaboration.

Why it matters

Potential benefit: If successful, participants may experience reduced risk of developing chronic PTSD and related symptoms.

How similar studies have gone: Earlier studies in other settings suggest brain stimulation can modulate fear and threat processing, but this early-post-trauma application is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women 18-65 years of age. (Assessed via self-reported and medical record-based Date of Birth)
* Trauma-exposed within the last 2 weeks (Endorsement of having experienced an event that could have caused death, serious injury, or sexual violence)
* High initial symptoms of PTSD related to the index trauma - PCL-5 \>30 AND at least 2 symptoms of hyperarousal.
* Low symptoms of PTSD related to a previous lifetime trauma - PCL-5\<31AND does not meet for all four DSM-5 clusters.
* Participants may be on psychotropic medication, including antidepressants, antipsychotics, benzodiazepines and anticonvulsants, but the dosage of the medication must be stable for at least 6 weeks and not change during the course of the study (Assessed via self-report during the screening phone call).
* Capable and willing to provide informed consent.

Exclusion Criteria:

* Having active suicidal intent or plan, or in the clinician's opinion, is likely to attempt suicide within the next six months. (Assessed via the Patient Health Questionnaire-9 (PHQ-9) during the screening phone call)
* Lifetime diagnosis of psychotic disorder or bipolar disorder per psychiatric screener. (Assessed via self-report during the screening phone call)
* Diagnosed with the following conditions: a neurological disorder, including a history of seizures, cerebrovascular disease, primary or secondary tumors in the central nervous system (CNS), stroke, cerebral aneurysm or movement disorder or any lifetime history of loss of consciousness for more than 5 minutes due to head injury (Assessed via self-report during the screening phone call)
* History of cranial surgery, metallic particles in the eye or head (exclusive of mouth), implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, intracranial implants (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes), or implanted medical pumps. (Assessed via self-report during the screening phone call)
* For women, being pregnant. (Assessed via self-report during the screening phone call, the medical record, and cycling females will undergo a pregnancy test at TMS Day 1)

Where it's running

  • Grady Memorial Hospital
    Atlanta, Georgia, United States
    Recruiting
  • Emory Brain Health Center
    Atlanta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.